We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Inquiry launched into whether study that created artificial form of disease should have gone through more checks
EcoHealth had already been criticised for failing to disclose details of Wuhan lab coronavirus work
Partnership with NIH agency is part of effort to expand global access to medicines
Deletion of early Wuhan cases evidence of ‘deliberate obfuscation’ of Covid’s origins, expert says
‘Gain of function’ experiments that make viruses more deadly should be more tightly controlled, say some scientists
Washington can boost global access to Covid shots by compelling technology sharing, says top NIH scientist
World’s largest healthcare company hopes to catch rivals working on two-jab products
National Institutes of Health panel says ‘insufficient’ evidence to back treatment touted by Trump
Health experts warn most vulnerable communities must be given priority
Highly unusual structure raises hopes for use of cancer drugs to treat the disease
Deliberately infecting volunteers could accelerate research but raises ethical questions
US-run trial of Gilead coronavirus therapy demonstrates ‘significant positive effect’
Covid-19 patients alerted mix of antimalarial medicine and antibiotic poses serious risks
US government hires Color to provide human touch in massive health data research project
The goal is to nurture a human organ, such as a pancreas, inside an engineered host animal
Health experts connect debut of 13 Reasons Why with rise in deaths
Women have long been excluded from biomedical studies, leading to less effective treatment
The government and taxpayers are the key investors in basic scientific research
Thousands volunteer for tests of experimental ‘Ad26 mosaic’
Tedros wins, US health cuts, obesity warning
Rare bipartisan agreement drops funding for Trump’s key campaign pledge
Proponents say vaccines made of RNA and DNA will prove safer and cheaper
Stanford University reacts to Brock Turner case by banning liquor, writes Philip Delves Broughton
Industry response contrasts with slow reaction to previous disease outbreaks, including Ebola
Scientists create organisms that contain the cells of humans and animals, writes Anjana Ahuja
International Edition
